Literature DB >> 16482219

The mechanism of repression of the myeloid-specific c-fms gene by Pax5 during B lineage restriction.

Hiromi Tagoh1, Richard Ingram, Nicola Wilson, Giorgia Salvagiotto, Alan J Warren, Deborah Clarke, Meinrad Busslinger, Constanze Bonifer.   

Abstract

The transcription factor Pax5 (BSAP) is required for the expression of a B-cell-specific genetic program and for B-cell differentiation, and also to suppress genes of alternative lineages. The molecular mechanism by which repression of myeloid genes occurs during early B-lineage restriction is unknown and in this study we addressed this question. One of the genes repressed by Pax5 in B cells is the colony-stimulating factor receptor 1 gene (csf1r or c-fms). We examined the changes in chromatin caused by Pax5 activity, and we show that Pax5 is directly recruited to c-fms resulting in the rapid loss of RNA polymerase II binding, followed by loss of transcription factor binding and DNaseI hypersensitivity at all cis-regulatory elements. We also show that Pax5 targets the basal transcription machinery of c-fms by interacting with a binding site within the major transcription start sites. Our results support a model by which Pax5 does not lead to major alterations in chromatin modification, but inhibits transcription by interfering with the action of myeloid transcription factors.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16482219      PMCID: PMC1409732          DOI: 10.1038/sj.emboj.7600997

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  49 in total

Review 1.  Identification of DNaseI hypersensitive sites within nuclei.

Authors:  P N Cockerill
Journal:  Methods Mol Biol       Date:  2000

2.  Structural studies of Ets-1/Pax5 complex formation on DNA.

Authors:  C W Garvie; J Hagman; C Wolberger
Journal:  Mol Cell       Date:  2001-12       Impact factor: 17.970

Review 3.  Differentiation plasticity of hematopoietic cells.

Authors:  Thomas Graf
Journal:  Blood       Date:  2002-05-01       Impact factor: 22.113

4.  Transcription factor-mediated lineage switching reveals plasticity in primary committed progenitor cells.

Authors:  Clare Heyworth; Stella Pearson; Gillian May; Tariq Enver
Journal:  EMBO J       Date:  2002-07-15       Impact factor: 11.598

5.  Reversion of B cell commitment upon loss of Pax5 expression.

Authors:  Ingvild Mikkola; Barry Heavey; Markus Horcher; Meinrad Busslinger
Journal:  Science       Date:  2002-07-05       Impact factor: 47.728

6.  Pax5 determines B- versus T-cell fate and does not block early myeloid-lineage development.

Authors:  Claudiu V Cotta; Zheng Zhang; Hyung-Gyoon Kim; Christopher A Klug
Journal:  Blood       Date:  2003-01-30       Impact factor: 22.113

7.  Transient expression of PU.1 commits multipotent progenitors to a myeloid fate whereas continued expression favors macrophage over granulocyte differentiation.

Authors:  Zoe McIvor; Sibyll Hein; Heike Fiegler; Timm Schroeder; Carol Stocking; Ursula Just; Michael Cross
Journal:  Exp Hematol       Date:  2003-01       Impact factor: 3.084

8.  Pax5 promotes B lymphopoiesis and blocks T cell development by repressing Notch1.

Authors:  Abdallah Souabni; Cesar Cobaleda; Michael Schebesta; Meinrad Busslinger
Journal:  Immunity       Date:  2002-12       Impact factor: 31.745

9.  Transcription factor complex formation and chromatin fine structure alterations at the murine c-fms (CSF-1 receptor) locus during maturation of myeloid precursor cells.

Authors:  Hiromi Tagoh; Roy Himes; Deborah Clarke; Pieter J M Leenen; Arthur D Riggs; David Hume; Constanze Bonifer
Journal:  Genes Dev       Date:  2002-07-01       Impact factor: 11.361

10.  A macrophage colony-stimulating factor receptor-green fluorescent protein transgene is expressed throughout the mononuclear phagocyte system of the mouse.

Authors:  R Tedjo Sasmono; Delvac Oceandy; Jeffrey W Pollard; Wei Tong; Paul Pavli; Brandon J Wainwright; Michael C Ostrowski; S Roy Himes; David A Hume
Journal:  Blood       Date:  2002-09-12       Impact factor: 22.113

View more
  16 in total

1.  RUNX1 regulates corepressor interactions of PU.1.

Authors:  Zhenbo Hu; Xiaorong Gu; Kristine Baraoidan; Vinzon Ibanez; Arun Sharma; ShriHari Kadkol; Reinhold Munker; Steven Ackerman; Giuseppina Nucifora; Yogen Saunthararajah
Journal:  Blood       Date:  2011-04-25       Impact factor: 22.113

2.  Common clonal origin of an acute B-lymphoblastic leukemia and a Langerhans' cell sarcoma: evidence for hematopoietic plasticity.

Authors:  Richard Ratei; Michael Hummel; Ioannis Anagnostopoulos; Doris Jähne; Renate Arnold; Bernd Dörken; Stephan Mathas; Thomas Benter; Oliver Dudeck; Wolf-Dieter Ludwig; Harald Stein
Journal:  Haematologica       Date:  2010-04-26       Impact factor: 9.941

3.  Conserved DNA sequence features underlie pervasive RNA polymerase pausing.

Authors:  Martyna Gajos; Olga Jasnovidova; Alena van Bömmel; Susanne Freier; Martin Vingron; Andreas Mayer
Journal:  Nucleic Acids Res       Date:  2021-05-07       Impact factor: 16.971

4.  Repeat-element driven activation of proto-oncogenes in human malignancies.

Authors:  Björn Lamprecht; Constanze Bonifer; Stephan Mathas
Journal:  Cell Cycle       Date:  2010-11-19       Impact factor: 4.534

Review 5.  CSF-1 receptor signaling in myeloid cells.

Authors:  E Richard Stanley; Violeta Chitu
Journal:  Cold Spring Harb Perspect Biol       Date:  2014-06-02       Impact factor: 10.005

6.  Runx1 regulation of Pu.1 corepressor/coactivator exchange identifies specific molecular targets for leukemia differentiation therapy.

Authors:  Xiaorong Gu; Zhenbo Hu; Quteba Ebrahem; John S Crabb; Reda Z Mahfouz; Tomas Radivoyevitch; John W Crabb; Yogen Saunthararajah
Journal:  J Biol Chem       Date:  2014-04-02       Impact factor: 5.157

7.  A two-step, PU.1-dependent mechanism for developmentally regulated chromatin remodeling and transcription of the c-fms gene.

Authors:  Hanna Krysinska; Maarten Hoogenkamp; Richard Ingram; Nicola Wilson; Hiromi Tagoh; Peter Laslo; Harinder Singh; Constanze Bonifer
Journal:  Mol Cell Biol       Date:  2006-11-20       Impact factor: 4.272

8.  Regulation of B cell fate commitment and immunoglobulin heavy-chain gene rearrangements by Ikaros.

Authors:  Damien Reynaud; Ignacio A Demarco; Karen L Reddy; Hilde Schjerven; Eric Bertolino; Zhengshan Chen; Stephen T Smale; Susan Winandy; Harinder Singh
Journal:  Nat Immunol       Date:  2008-06-22       Impact factor: 25.606

9.  Epigenetic regulation of B lymphocyte differentiation, transdifferentiation, and reprogramming.

Authors:  Bruna Barneda-Zahonero; Lidia Roman-Gonzalez; Olga Collazo; Tokameh Mahmoudi; Maribel Parra
Journal:  Comp Funct Genomics       Date:  2012-08-26

10.  The function of the conserved regulatory element within the second intron of the mammalian Csf1r locus.

Authors:  Kristin A Sauter; M Amine Bouhlel; Julie O'Neal; David P Sester; Hiromi Tagoh; Richard M Ingram; Clare Pridans; Constanze Bonifer; David A Hume
Journal:  PLoS One       Date:  2013-01-31       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.